The Valley Desk

NCT01616199 · Interventional trial

Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma

Overall registry status Terminated

Phase 1 · Phase 2

Conditions Advanced BRAF-mutant Cancers

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov